Verve Therapeutics, Inc. (VERV) Analyst Forecast

$6.05

south_east -$0.26 (-4.05%)
Day's range
$5.92
Day's range
$6.53

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
11/06/2024 H.C. Wainwright Mitchell Kapoor $14.00 $6.32   121.69%
04/03/2024 BMO Capital Kostas Biliouris $30.00 $8.57   250.06%

Verve Therapeutics, Inc. FAQ's

What analysts cover Verve Therapeutics, Inc.?

Verve Therapeutics, Inc. has been rated by research analysts at H.C. Wainwright, BMO Capital, Goldman Sachs in the past 90 days.